Molnupiravir is the first oral antiviral treatment for Covid to report clinical trial results. The first pill designed to treat symptomatic Covid has been approved by the UK medicines regulator.
Last week, the UK said it had secured 480,000 doses of molnupiravir, along with 250,00 courses of another antiviral medicine developed by Pfizer that is based on new compound PF-07321332 and a low ...